XF
IBB icon

XML Financial’s iShares Biotechnology ETF IBB Stock Holding History

XML Financial’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296K Buy
+1,555
New +$267K 0.02% 374
2026
Q1 		– Sell
-1,614
Closed -$272K – 441
2025
Q4 		$272K Buy
+1,614
New +$262K 0.02% 357
2024
Q4 		– Sell
-2,447
Closed -$356K – 368
2024
Q3 		$356K Sell
2,447
-320
-12% -$46.3K 0.03% 273
2024
Q2 		$380K Sell
2,767
-251
-8% -$33.5K 0.04% 249
2024
Q1 		$414K Buy
3,018
+2
+0.1% +$273 0.04% 245
2023
Q4 		$410K Buy
3,016
+255
+9% +$31.1K 0.04% 231
2023
Q3 		$338K Hold
2,761
– – 0.04% 244
2023
Q2 		$350K Buy
2,761
+1
+0% +$130 0.04% 255
2023
Q1 		$357K Buy
2,760
+1
+0% +$131 0.04% 247
2022
Q4 		$362K Buy
2,759
+73
+3% +$9.43K 0.05% 237
2022
Q3 		$314K Buy
2,686
+3
+0.1% +$373 0.04% 241
2022
Q2 		$316K Buy
2,683
+475
+22% +$56.4K 0.07% 171
2022
Q1 		$288K Buy
2,208
+198
+10% +$25.8K 0.03% 266
2021
Q4 		$307K Buy
+2,010
New +$311K 0.04% 258

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

XML Financial's IBB Position: Q2 2026 in Review

XML Financial opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 1,555 shares worth $296K. The stake represents 0.02% of the portfolio and ranks #374 among its holdings. This is a return to the name: XML Financial previously reported a position in IBB as recently as Q4 2025.

XML Financial first reported a position in IBB in Q4 2021 and has held it in 14 quarters since. The position peaked at $414K in Q1 2024. 955 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • XML Financial held 1,555 shares of iShares Biotechnology ETF worth $296K as of Q2 2026.
  • iShares Biotechnology ETF was a new XML Financial position in Q2 2026.
  • iShares Biotechnology ETF made up 0.02% of XML Financial's portfolio in Q2 2026, its #374 holding.
  • XML Financial first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 14 quarters since.
  • XML Financial's iShares Biotechnology ETF position peaked at $414K in Q1 2024.
  • 955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on XML Financial's 13F filing for Q2 2026, filed 24 Jul 2026.